Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cytosorbents Cor (NQ: CTSO )

9.420 USD +0.170 (+1.84%)
Official Closing Price Updated: 4:41 PM EDT, Apr 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 161,638
Open 9.330
Bid (Size) 8.630 (10)
Ask (Size) 9.450 (1)
Prev. Close 9.250
Today's Range 9.200 - 9.470
52wk Range 7.130 - 11.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CytoSorbents Announces Lease of New Global Headquarters in Princeton, New Jersey
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac... 
From PR Newswire
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic Surgery
CytoSorbents Corporation (NASDAQ: CTSO) announces the filing of an Investigational Device Exemption (IDE) application to conduct the clinical study, "Safe and Timely Antithrombotic Removal - Ticagrelor... 
From PR Newswire

Performance

YTD
+12.54%
+12.54%
1 Month
+1.02%
+1.02%
3 Month
+2.95%
+2.95%
6 Month
+8.90%
+8.90%
1 Year
+22.02%
+22.02%

More News

Read More
CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference
From PR Newswire
CytoSorbents Announces 2020 Financial and Operational Results
From PR Newswire
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
From PR Newswire
CytoSorbents to Report Fiscal 2020 Operating and Financial Results
From PR Newswire
CytoSorbents to Present at the Cowen 41st Annual Health Care Conference
From PR Newswire
CytoSorbents 2021: Leadership and Growth in the "New Normal"
From PR Newswire
CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference
From PR Newswire
National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery
From PR Newswire
CytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global Regulatory Affairs
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.